Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Menopause matters: optimising menopause management
Helping women navigate menopause with timely support, informed treatment choices and greater understanding throughout the transition.
2018 PSA Offshore Refresher Conference
Delegates from the 43rd annual PSA Offshore Refresher conference have recently returned from host city San Francisco, where they networked while learning about the...
Psychotropic self-poisoning on the rise in youth
A new retrospective cohort study has found that self-poisoning, by ingesting psychotropic medicines, in Australian children and adolescents is increasing. The prescribed medicines...
Caring for our elders
This Royal Commission is an opportunity to improve how we care for our elderly, and release the chains holding pharmacists back from preventing inappropriate...
COVID-19 spreading locally
Health authorities have urged Australians returning from Iran to self-quarantine for 14 days as Australia reports its first cases of human-to-human transmission of COVID-19.
There...













